Stabilization of ascorbic acid in human plasma, and its liquid-chromatographic measurement

S. A. Margolis, Thomas P Davis

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

We describe two independent HPLC procedures for the rapid, accurate analysis for ascorbic acid in human plasma. No sample extraction or phase separation is required. We also describe a procedure for preparing a human plasma reference material for use in clinical laboratory analysis for ascorbic acid. The ascorbic acid in plasma can be determined in 15 min, with as little as 50 μL of sample. Analytical recoveries are near 100% with direct injection of deproteinized plasma. Extensive stability data under several conditions, with dithiothreitol as a preservative (antioxidant), indicate that ascorbic acid remains stable in stored plasma for as long as 57 weeks. CVs for round-robin analysis of 11 normal human blood samples by two independent methods were between 0.1% and 5.3%. These clinical samples appear to be stable for at least 50 days under the described conditions of stabilization and sample treatment. Finally, because ascorbic acid prepared by the described procedures is stable at room temperature for at least 18 h, these methods can be readily adapted to clinical laboratory automation at room temperature.

Original languageEnglish (US)
Pages (from-to)2217-2223
Number of pages7
JournalClinical Chemistry
Volume34
Issue number11
StatePublished - 1988
Externally publishedYes

Fingerprint

Plasma (human)
Ascorbic Acid
Stabilization
Clinical laboratories
Liquids
Plasmas
Laboratory Automation
Songbirds
Temperature
Dithiothreitol
Direct injection
Phase separation
Blood
Automation
Antioxidants
High Pressure Liquid Chromatography
Recovery
Injections

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Stabilization of ascorbic acid in human plasma, and its liquid-chromatographic measurement. / Margolis, S. A.; Davis, Thomas P.

In: Clinical Chemistry, Vol. 34, No. 11, 1988, p. 2217-2223.

Research output: Contribution to journalArticle

@article{8fdc7be461134e72b94c95df2663712c,
title = "Stabilization of ascorbic acid in human plasma, and its liquid-chromatographic measurement",
abstract = "We describe two independent HPLC procedures for the rapid, accurate analysis for ascorbic acid in human plasma. No sample extraction or phase separation is required. We also describe a procedure for preparing a human plasma reference material for use in clinical laboratory analysis for ascorbic acid. The ascorbic acid in plasma can be determined in 15 min, with as little as 50 μL of sample. Analytical recoveries are near 100{\%} with direct injection of deproteinized plasma. Extensive stability data under several conditions, with dithiothreitol as a preservative (antioxidant), indicate that ascorbic acid remains stable in stored plasma for as long as 57 weeks. CVs for round-robin analysis of 11 normal human blood samples by two independent methods were between 0.1{\%} and 5.3{\%}. These clinical samples appear to be stable for at least 50 days under the described conditions of stabilization and sample treatment. Finally, because ascorbic acid prepared by the described procedures is stable at room temperature for at least 18 h, these methods can be readily adapted to clinical laboratory automation at room temperature.",
author = "Margolis, {S. A.} and Davis, {Thomas P}",
year = "1988",
language = "English (US)",
volume = "34",
pages = "2217--2223",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "11",

}

TY - JOUR

T1 - Stabilization of ascorbic acid in human plasma, and its liquid-chromatographic measurement

AU - Margolis, S. A.

AU - Davis, Thomas P

PY - 1988

Y1 - 1988

N2 - We describe two independent HPLC procedures for the rapid, accurate analysis for ascorbic acid in human plasma. No sample extraction or phase separation is required. We also describe a procedure for preparing a human plasma reference material for use in clinical laboratory analysis for ascorbic acid. The ascorbic acid in plasma can be determined in 15 min, with as little as 50 μL of sample. Analytical recoveries are near 100% with direct injection of deproteinized plasma. Extensive stability data under several conditions, with dithiothreitol as a preservative (antioxidant), indicate that ascorbic acid remains stable in stored plasma for as long as 57 weeks. CVs for round-robin analysis of 11 normal human blood samples by two independent methods were between 0.1% and 5.3%. These clinical samples appear to be stable for at least 50 days under the described conditions of stabilization and sample treatment. Finally, because ascorbic acid prepared by the described procedures is stable at room temperature for at least 18 h, these methods can be readily adapted to clinical laboratory automation at room temperature.

AB - We describe two independent HPLC procedures for the rapid, accurate analysis for ascorbic acid in human plasma. No sample extraction or phase separation is required. We also describe a procedure for preparing a human plasma reference material for use in clinical laboratory analysis for ascorbic acid. The ascorbic acid in plasma can be determined in 15 min, with as little as 50 μL of sample. Analytical recoveries are near 100% with direct injection of deproteinized plasma. Extensive stability data under several conditions, with dithiothreitol as a preservative (antioxidant), indicate that ascorbic acid remains stable in stored plasma for as long as 57 weeks. CVs for round-robin analysis of 11 normal human blood samples by two independent methods were between 0.1% and 5.3%. These clinical samples appear to be stable for at least 50 days under the described conditions of stabilization and sample treatment. Finally, because ascorbic acid prepared by the described procedures is stable at room temperature for at least 18 h, these methods can be readily adapted to clinical laboratory automation at room temperature.

UR - http://www.scopus.com/inward/record.url?scp=0024270657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024270657&partnerID=8YFLogxK

M3 - Article

C2 - 3180412

AN - SCOPUS:0024270657

VL - 34

SP - 2217

EP - 2223

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 11

ER -